Sort
23,748 grants matching “melanoma”
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$534,470Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Tumor Stroma Interactions: Wound Promoted Tumor Growth
$534,303John Niederhuber · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HTS for Direct Targeting of the Transcription Factor MITF
$534,190Thomas J. Kodadek · Scripps Florida · R01 · FY2016 · CA
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
$533,951Emily H Cheng · Sloan-Kettering Inst Can Research · U54 · FY2022 · CA
CDKN2A couples lipid metabolism to ferroptosis in glioblastoma
$533,806David A. Nathanson · University Of California Los Angeles · R01 · FY2021 · NS
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$533,720Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2019 · CA
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity
$533,556Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,358Anton Wellstein · Georgetown University · R01 · FY2021 · CA
Biology of Fungal Melanin
$533,349Arturo Casadevall · Johns Hopkins University · R01 · FY2017 · AI
Biology of Fungal Melanin
$533,349Arturo Casadevall · Johns Hopkins University · R01 · FY2019 · AI
Biology of Fungal Melanin
$533,349Arturo Casadevall · Johns Hopkins University · R01 · FY2018 · AI
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,344Anton Wellstein · Georgetown University · R01 · FY2020 · CA
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss
$533,267Tal Teitz · Scintillon Institute For Photobiology · R01 · FY2024 · DC
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss
$533,267Tal Teitz · Scintillon Institute For Photobiology · R01 · FY2025 · DC
Clinical Protocol and Data Management/Clinical Trials Office (Core 016)
$533,223Adam M Brufsky · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$533,211Anton Wellstein · Georgetown University · R01 · FY2018 · CA
Biology of Fungal Melanin
$533,181Arturo Casadevall · Johns Hopkins University · R01 · FY2016 · AI
Pilot Project Program
$533,055Raymond E Samuel · Hampton University · U54 · FY2014 · MD
Tissue Resident memory T cell responses to cancer
$532,934Mary J Turk · Dartmouth College · R01 · FY2021 · CA
Tissue Resident memory T cell responses to cancer
$532,934Mary J Turk · Dartmouth College · R01 · FY2020 · CA
Descriptive Studies and Record Linkage
$532,689Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Processed Antigen Characterization by Mass Spectrometry
$532,685Donald F Hunt · University Of Virginia · R01 · FY2012 · AI
Glycosylation Mutants of Mice and Animal Cells
$532,632Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2010 · CA
Clinical production of viral vectors for cancer gene therapy
$532,491Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy
$532,395Alexander Huang · University Of Pennsylvania · R01 · FY2022 · CA